161 related articles for article (PubMed ID: 33247498)
1. Current experimental human tissue-derived models for prostate cancer research.
Kato M; Sasaki T; Inoue T
Int J Urol; 2021 Feb; 28(2):150-162. PubMed ID: 33247498
[TBL] [Abstract][Full Text] [Related]
2. Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research.
Waseem M; Wang BD
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256166
[TBL] [Abstract][Full Text] [Related]
3. Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer.
Wadosky KM; Wang Y; Zhang X; Goodrich DW
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31259888
[TBL] [Abstract][Full Text] [Related]
4. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
[TBL] [Abstract][Full Text] [Related]
5. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
6. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
Cao J; Chan WC; Chow MSS
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35322860
[TBL] [Abstract][Full Text] [Related]
7. Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.
Namekawa T; Ikeda K; Horie-Inoue K; Inoue S
Cells; 2019 Jan; 8(1):. PubMed ID: 30669516
[TBL] [Abstract][Full Text] [Related]
8. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
9. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
Pyo DH; Hong HK; Lee WY; Cho YB
Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
[TBL] [Abstract][Full Text] [Related]
11. New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine.
Rago V; Perri A; Di Agostino S
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893116
[TBL] [Abstract][Full Text] [Related]
12. Defining the challenges and opportunities for using patient-derived models in prostate cancer research.
Brennen WN; Le Magnen C; Karkampouna S; Anselmino N; Bock N; Choo N; Clark AK; Coleman IM; Dolgos R; Ferguson AM; Goode DL; Krutihof-de Julio M; Navone NM; Nelson PS; O'Neill E; Porter LH; Ranasinghe W; Sunada T; Williams ED; Butler LM; Corey E; van Weerden WM; Taylor RA; Risbridger GP; Lawrence MG
Prostate; 2024 May; 84(7):623-635. PubMed ID: 38450798
[TBL] [Abstract][Full Text] [Related]
13. Engineering prostate cancer in vitro: what does it take?
Buskin A; Scott E; Nelson R; Gaughan L; Robson CN; Heer R; Hepburn AC
Oncogene; 2023 Aug; 42(32):2417-2427. PubMed ID: 37438470
[TBL] [Abstract][Full Text] [Related]
14. What role could organoids play in the personalization of cancer treatment?
Francies HE; Garnett MJ
Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
[TBL] [Abstract][Full Text] [Related]
15. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
16. Organoid development in cancer genome discovery.
Gao D; Chen Y
Curr Opin Genet Dev; 2015 Feb; 30():42-8. PubMed ID: 25796043
[TBL] [Abstract][Full Text] [Related]
17. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
[TBL] [Abstract][Full Text] [Related]
18. The potential of organoids in urological cancer research.
Wang S; Gao D; Chen Y
Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
[TBL] [Abstract][Full Text] [Related]
19. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models.
Risbridger GP; Toivanen R; Taylor RA
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29311126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
